Stock Scorecard
Stock Summary for Outset Medical Inc (OM) - $2.53 as of 5/1/2024 5:33:09 PM EST
Total Score
11 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for OM
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OM
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OM
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for OM
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for OM
Financial Details for OM
Company Overview |
|
---|---|
Ticker | OM |
Company Name | Outset Medical Inc |
Country | USA |
Description | Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. The company is headquartered in San Jose, California. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/29/2024 |
Stock Price History |
|
Last Day Price | 2.53 |
Last Day Price Updated | 5/1/2024 5:33:09 PM EST |
Last Day Volume | 544,254 |
Average Daily Volume | 925,017 |
52-Week High | 24.13 |
52-Week Low | 1.92 |
Last Price to 52 Week Low | 31.77% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 46.57 |
Sector PE | 53.36 |
5-Year Average PE | -7.56 |
Free Cash Flow Ratio | 0.64 |
Industry Free Cash Flow Ratio | 18.51 |
Sector Free Cash Flow Ratio | 30.86 |
Current Ratio Most Recent Quarter | 5.26 |
Total Cash Per Share | 3.93 |
Book Value Per Share Most Recent Quarter | 2.44 |
Price to Book Ratio | 0.84 |
Industry Price to Book Ratio | 3.23 |
Sector Price to Book Ratio | 22.00 |
Price to Sales Ratio Twelve Trailing Months | 0.79 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.52 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.14 |
Share Statistics |
|
Total Shares Outstanding | 51,702,000 |
Market Capitalization | 130,806,060 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -6.04% |
Reported EPS 12 Trailing Months | -3.48 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -3.10 |
Net Income Twelve Trailing Months | -172,797,000 |
Net Income Past Year | -172,797,000 |
Net Income Prior Year | -162,956,000 |
Quarterly Revenue Growth YOY | -4.70% |
5-Year Revenue Growth | 37.53% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 203,324,000 |
Total Cash Past Year | 203,324,000 |
Total Cash Prior Year | 287,500,000 |
Net Cash Position Most Recent Quarter | 73,211,000 |
Net Cash Position Past Year | 73,211,000 |
Long Term Debt Past Year | 130,113,000 |
Long Term Debt Prior Year | 96,336,000 |
Total Debt Most Recent Quarter | 130,113,000 |
Equity to Debt Ratio Past Year | 0.49 |
Equity to Debt Ratio Most Recent Quarter | 0.49 |
Total Stockholder Equity Past Year | 122,886,000 |
Total Stockholder Equity Prior Year | 245,990,000 |
Total Stockholder Equity Most Recent Quarter | 122,886,000 |
Options |
|
Put/Call Ratio | 0.04 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.06 |
MACD Signal | -0.12 |
20-Day Bollinger Lower Band | 0.89 |
20-Day Bollinger Middle Band | 3.44 |
20-Day Bollinger Upper Band | 5.98 |
Beta | 1.98 |
RSI | 54.43 |
50-Day SMA | 9.76 |
200-Day SMA | 0.00 |
System |
|
Modified | 4/30/2024 7:40:55 AM EST |